https://bsky.app/profile/drmichelleboyle.bsky.socialhttps://bsky.app/profile/drmichelleboyle.bsky.social/post/3m6kvwg7e4c2gSo pleased to share our study of a host-directed therapy to boost malaria immunity. Adjunctive ruxolitinib attenuates inflammation and enhances immunity in volunteers experimentally infected with Plasmodium falciparum | Science Translational Medicine https://www.science.org/doi/10.1126/scitranslmed.aea253126 Nov 2025 22:32 +0000at://did:plc:2jmojm7e4wxtez55k2qdfogs/app.bsky.feed.post/3m6kvwg7e4c2g